Anti-CD3E Recombinant Antibody (Visilizumab) (CAT#: TAB-714)
30 August 2023
Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. Visilizumab is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in [...]